Search
"People don’t consider that there will be a life after diagnosis"
Latest news, posted 1 March 2023
Beverley has been a Macular Society counsellor for more than 20 years. In this time she has spoken to hundreds of people struggling to come to terms with the life-changing diagnosis of macular disease.
Help abolish VAT on audiobooks
Latest news, posted 1 March 2023
An MP is leading a call in Parliament to abolish VAT on audiobooks, to support people with visual impairments.
Do you suffer from pain after your eye injection?
Latest news, posted 3 April 2023
While many people don’t experience any problems from their regular eye injections, there are a few others who have complained about pain or discomfort in the hours following the treatment.
Workforce Census illustrates severe shortage of eye doctors
Latest news, posted 31 March 2023
The Macular Society has reacted with concern to The Royal College of Ophthalmologist’s 2022 Workforce Census, which reveals the shortage of eye doctors in the UK and the extent of pressure on NHS ophthalmology services.
“I wanted to do something to challenge myself”
Latest news, posted 31 March 2023
A grandmother of four with age-related macular degeneration (AMD) will be taking on her first-ever marathon this month, at the age of 70.
Cyfrifiad y Gweithlu yn dangos prinder difrifol o feddygon llygad
Latest news, posted 31 March 2023
Mae'r Gymdeithas Facwlaidd wedi ymateb gyda phryder i Gyfrifiad y Gweithlu 2022 gan Goleg Brenhinol yr Offthalmolegwyr, sy'n datgelu prinder o feddygon llygad yn y DU a maint y pwysau sydd ar wasanaethau offthalmoleg y GIG.
Changes to voting affecting blind and partially sighted people
Latest news, posted 3 April 2023
The local elections next month will be the first time people across the country will be asked to provide photo ID in order to vote.
New drug for dry AMD - Syfovre: your questions answered
Latest news, posted 4 April 2023
In February we shared the exciting news that the first-ever drug to treat dry age-related macular degeneration (AMD) has been approved in the US. With the support of Apellis Pharmaceuticals, which has brought the drug to market, we answer some of your most frequently asked questions.
What is the macula?
What is macular disease?
The macula is part of the retina at the back of the eye. It’s a round, yellow spot that has a slight oval shape and is only about 5mm across, but is responsible for our central vision, most of our colour vision and the fine detail of what we see.
Macular conditions
What is macular disease?
Nearly 1.5m people in the UK have macular disease. It affects people of all ages. Age-related macular degeneration (AMD) is the most common condition, generally affecting people over the age of 55. AMD is the biggest cause of sight loss in the UK, affecting more than 700,000 people.